Sorriso Pharmaceuticals
Internet Service Providers · Network Security
Overview
About Sorriso Pharmaceuticals Sorriso is a biopharmaceutical company advancing a pipeline of disease-modifying antibodies for the treatment of immune-mediated diseases, including Crohn’s disease and ulcerative colitis.
Funding and backers
Backers
1
NEA
Momentum
0/100
no fresh signals
Backed byfrom the funds' portfolios and accelerator catalogs
Investors in similar startupsfunds that back the companies most like this one
backs Alumis, Third Arc Bio
backs Alumis
Similar startupsby what they do, their industry and backers
We are using a precision approach to develop therapies designed to transform the lives of patients with immune-mediated diseases.
Bionyra Pharma is a clinical-stage biopharmaceutical company developing next-generation biologics for severe immune-mediated inflammatory…
Third Arc Bio is advancing antibody technology by unlocking the powerful biology of immune synapses to address solid tumors and autoimmune…
Valora Therapeutics is developing AbLec™ multispecific antibodies and T-Lec™ T cell engagers — antibody-engineering platforms that decoy…
At RedRidge, we are leaders in the identification and development of biparatopic antibodies, designed to deliver exceptional efficacy…
Advancing innovative therapies for immune-mediated diseases.. This page is strictly for career opportunities.
Connections
List
Graph
Found in company registers, site code, DNS and hiring. Each connection shows how sure we are and the evidence, with its source and date.
Shared investors
NEAVia a fund
672 portfolio companies
Click a company to open it. Dashed lines are likely connections. The second step of the network is part of the Pro plan.
Owner
Same company
Same group
Likely